INSTITUT DE RECHERCHE CONTRE LES CANCERS DE L'APPAREIL DIGESTIF

Their core work

IRCAD is a world-renowned French surgical research institute based in Strasbourg, specialized in digestive cancer treatment and minimally invasive surgery. They serve as a clinical validation environment and research partner for advanced surgical technologies — bridging the gap between engineering prototypes and real operating room deployment. Their H2020 work spans two distinct but complementary tracks: developing autonomous robotic systems for intraluminal surgery (colonoscopy, ureteroscopy, vascular intervention) and addressing the biosafety risks of laparoscopic and endoscopic procedures in pandemic conditions. As a rare institution that combines active surgical practice with deep technology research, they offer credibility that purely academic partners cannot.

What they specialise in

How they've shifted over time

IRCAD's H2020 engagement began with a focus on surgical robotics and autonomous navigation — the ATLAS project (starting 2019) placed them at the intersection of continuum robotics, active catheters, and real-time 3D reconstruction for intraluminal procedures. Their second project, PORSAV (starting 2020), represents a sharp pivot driven by the COVID-19 pandemic: the same surgical environments (laparoscopy, endoscopy) suddenly became the subject of biosafety investigation, with IRCAD contributing clinical expertise on aerosol leakage and vacuum-based containment. The trajectory shows an organization willing to redirect its clinical knowledge base toward urgent applied problems, while maintaining minimally invasive surgery as the constant through-line.

IRCAD is moving from pure surgical technology development toward broader clinical safety infrastructure, suggesting future relevance in topics like OR environment monitoring, infection prevention in endoscopic settings, and human-robot interaction in sterile environments.

How they like to work

IRCAD has never held a coordinator role in H2020 — they join consortia as a specialist clinical partner or third party, contributing validated surgical environments and domain expertise rather than administrative leadership. Despite only two projects, they engaged with 24 unique partners across 8 countries, which points to participation in large, multi-institutional consortia where their role is focused and high-value rather than broad. Working with them likely means access to a real surgical facility and clinical credibility in return for their consortium slot.

IRCAD connected with 24 unique partners across 8 countries through just two projects, reflecting involvement in large European consortia rather than bilateral arrangements. Their network spans both the research excellence and health pillars, indicating connections to both academic engineering teams and clinical/public health communities.

What sets them apart

IRCAD occupies a rare position as a research institute that is simultaneously a working surgical center — they do not just study minimally invasive surgery, they practice it, which makes their project contributions clinically grounded in a way most university labs cannot match. Their international reputation in surgical simulation and laparoscopic technique training (their physical facility in Strasbourg is used by surgeons worldwide) gives consortium partners immediate credibility with clinical evaluators and ethics committees. For technology developers working on surgical robotics, imaging, or OR safety, IRCAD is the kind of clinical anchor that turns a promising prototype into a publishable and fundable result.

Highlights from their portfolio

• ATLAS
  An MSCA Innovation Training Network focused on fully autonomous intraluminal surgery — one of the most technically ambitious robotic surgery projects in H2020, covering continuum robotics, active catheters, and autonomous navigation across multiple anatomical sites.
• PORSAV
  Directly funded with EUR 448,740 as an Innovation Action, PORSAV addressed a real-time public health crisis — viral aerosol risk during laparoscopic and endoscopic surgery — using schlieren imaging and vacuum containment, representing IRCAD's ability to mobilize clinical expertise for urgent applied problems.